Norway Hospital Acquired Infections Diagnostics Market Size & Outlook
Norway hospital acquired infections diagnostics market, 2018-2030 (US$M)
Related Markets
Norway hospital acquired infections diagnostics market highlights
- The Norway hospital acquired infections diagnostics market generated a revenue of USD 15.6 million in 2024 and is expected to reach USD 16.3 million by 2030.
- The Norway market is expected to grow at a CAGR of 0.7% from 2025 to 2030.
- In terms of segment, conventional was the largest revenue generating test type in 2024.
- Molecular is the most lucrative test type segment registering the fastest growth during the forecast period.
Hospital acquired infections diagnostics market data book summary
| Market revenue in 2024 | USD 15.6 million |
| Market revenue in 2030 | USD 16.3 million |
| Growth rate | 0.7% (CAGR from 2025 to 2030) |
| Largest segment | Conventional |
| Fastest growing segment | Molecular |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Molecular, Conventional |
| Key market players worldwide | BioMerieux SA, Abbott, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG ADR, Becton Dickinson & Co, Qiagen NV, Thermo Fisher Scientific Inc, Meridian Bioscience, Hologic, Inc. |
Other key industry trends
- In terms of revenue, Norway accounted for 0.4% of the global hospital acquired infections diagnostics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany hospital acquired infections diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 371.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Hospital Acquired Infections Diagnostics Market Scope
Hospital Acquired Infections Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Norway hospital acquired infections diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hospital acquired infections diagnostics market will help companies and investors design strategic landscapes.
Conventional was the largest segment with a revenue share of 55.13% in 2024. Horizon Databook has segmented the Norway hospital acquired infections diagnostics market based on molecular, conventional covering the revenue growth of each sub-segment from 2018 to 2030.
The high prevalence of hospital-acquired infections (HAIs) in Norway has been a significant driver for the growth of the country's HAI control market. According to a survey by the European Centre for Disease Prevention and Control in acute care hospitals – 2022-2023, around 10.45 of the patients admitted to these facilities acquire healthcare-associated infection, which is significantly higher than the EU average of 6.8%.
Multinational corporations maintain a strong foothold due to their innovative diagnostic platforms, extensive R&D investments, and well-established distribution networks.
These players dominate the market with advanced technologies such as PCR-based molecular diagnostics and rapid antigen tests, which are highly valued for their accuracy and speed in detecting HAIs.
Reasons to subscribe to Norway hospital acquired infections diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Norway hospital acquired infections diagnostics market databook
-
Our clientele includes a mix of hospital acquired infections diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway hospital acquired infections diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Norway hospital acquired infections diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Norway Test Type - Hospital Acquired Infections Diagnostics Market size, 2024 - 2030 (US$M)
Norway Hospital Acquired Infections Diagnostics Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
